Diagnosis and management of monogenic cerebral small vessel diseases

Affiliations

¹ Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
² Department of Neurology, Division of Cerebrovascular Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Editorial

R Saito et al. Eur J Neurol. 2020 Jul.

. 2020 Jul;27(7):1097-1098.

doi: 10.1111/ene.14222. Epub 2020 May 12.

¹ Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
² Department of Neurology, Division of Cerebrovascular Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.

No abstract available

Comment on

Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.
Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, Enzinger C, Federico A, Filla A, Finsterer J, Hunt D, Lesnik Oberstein S, Tournier-Lasserve E, Markus HS. Mancuso M, et al. Eur J Neurol. 2020 Jun;27(6):909-927. doi: 10.1111/ene.14183. Epub 2020 Mar 20. Eur J Neurol. 2020. PMID: 32196841

1. Mancuso M, Arnold M, Bersano A, et al. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol 2020; 27: 909-927.
1. Verdura E, Herve D, Scharrer E, et al. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain 2015; 138(234): 7-2358.
1. Bulgiani M, Kevelam SH, Bakels HS, et al. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology 2016; 87: 1777-1786.